Stem Cells Treatment for Stroke
Recent clinical trial conducted by
investigators of Sandford’s University has proven the efficacy and feasibility
of adult stem cells from human tissues; in restoration and functional
modification of chronic stroke patients. Furthermore, the trial has suggested
that all stroke patients, with the recent attack between six months to three
years remained conscious under general light anaesthesia.
Stem cells are the natural super cells of
human body, giving rise to muscles, fat, bone and tendons. Although, primary
clinical investigation reported further that these stem cells don’t exhibit any
tumorigenic properties by differentiating into unwanted cells and tissues. The
technology has enabled easy isolation of stem cells from body’s own sources,
such as bone marrow as well as adipose tissues; being isolated from body’s own
sources, they did not pose any attributable side effects, neither did they link
to any life threatening adverse effects, post procedure. The principal
investigators of the trial were quite happy with the outcome, and confirmed
that the improvement they could notice was statistically significant and
clinically meaningful.
Stroke is being identified as the second
leading cause of death worldwide, with each year nearly 8,00,000 people
suffering with it. It has been as well reported that amongst the total reported
cases, nearly 85% people are suffering with ischemic stroke, due to formation of blood clots
in a blood vessel supplying oxygenated blood to the affected area. Remaining
15% patients are estimated to be suffering with haemorrhagic stroke, occurring
due to rupture of blood vessels. Currently, no gold standard treatment is
available, except for administration of some steroidal, anti-inflammatory
medicines; offered to manage the issue. Accordingly, application of stem cells
therapy can be clinically effective option with added advantage of safety and
feasibility as evident through many clinical trials.
Many scientists have offered their candid
acceptance for the use of autologous body sources, for therapeutic
interventions; rather than switching over to artificially structured sources,
considering their safety, feasibility and ethical acceptance. It would not be
surprising to say that these autologous adult stem cells sources are being
tried and tested for more than a decade, with a great available data for
effective cell dose, route of administration, safety profile, etc. Although,
stem cells intrinsic mechanism is still very vague; scientist could able to
analyse their superficial foot prints; in order to optimize their clinical
transplant regimen. Thus, with the current available knowledge scientists are
claiming to have gained better understanding of their signalling pathways to
establish respectable profile towards their multilineage differentiation. In
this regard, a choice of route of delivery depends upon therapeutic indication
and a local administration through intra-cerebral delivery; while it has been
evident that intra-venous as well as intra-arterial injections.
Thus, the effective clinical outcome from
bench to bedside approach are found to be very helpful in authenticating and
validating further to practice bench to bedside approach for further
development of neurorestorative stroke therapies. Although, still many of the
questions are to be resolved, considering current scenario; stem cells therapy can be powerful treatment
alternatives.
Comments
Post a Comment